SPONSOR
Valenta Pharm JSC
Total Trials
2
Recruiting
2
Phases
Phase 4
Conditions studied: AnxietyNeurastheniaAdjustment DisordersHeartburnAcid-dependent Diseases of the Gastrointestinal TractSymptomatic Treatment of Gastric and Duodenal Ulcers
NCT06843044 Phase 4
Recruiting
Efficacy and Safety of Ranquilon in Patients With Anxiety Disorders Due to Neurasthenia and Adjustment Disorders
Anxiety
NCT06098742
Recruiting
Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg/10 ml Oral Suspension and Riopan 800 mg Chewable Tablets in Healthy Volunteers
Heartburn